Cite Filings / SLS / 0001193125-25-282690

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

SELLAS Life Sciences Group, Inc. Filed 2025-11-14 Acc 0001193125-25-282690

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-07-31 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-21 CORRESP Correspondence Between Filers and SEC Staff
2025-11-21 4 Director bought 63,400 shares at $1.59 ($100,806)
2025-11-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-12 8-K Results of operations
2025-11-12 10-Q Quarterly Report
2025-10-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…